Arrowhead Pharmaceuticals Stock Price History
| ARWR Stock | USD 14.80 0.31 2.05% |
Below is the normalized historical share price chart for Arrowhead Pharmaceuticals extending back to December 16, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arrowhead Pharmaceuticals stands at 14.80, as last reported on the 24th of March, with the highest price reaching 15.22 and the lowest price hitting 14.69 during the day.
If you're considering investing in Arrowhead Stock, it is important to understand the factors that can impact its price. Arrowhead Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Arrowhead Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arrowhead Pharmaceuticals' Mean Deviation of 2.71, standard deviation of 3.51, and Risk Adjusted Performance of (0.13) to double-check the risk estimate we provide.
At this time, Arrowhead Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 03/24/2025, Common Stock Total Equity is likely to grow to about 239.1 K, while Preferred Stock Total Equity is likely to drop 13.68. . At this time, Arrowhead Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 03/24/2025, Price To Book Ratio is likely to grow to 11.82, while Price Earnings Ratio is likely to drop (4.67). Arrowhead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of June 1993 | 200 Day MA 21.7145 | 50 Day MA 18.5573 | Beta 0.922 |
Arrowhead |
Sharpe Ratio = -0.1184
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARWR |
Estimated Market Risk
| 3.46 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arrowhead Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arrowhead Pharmaceuticals by adding Arrowhead Pharmaceuticals to a well-diversified portfolio.
Price Book 38.658 | Enterprise Value Ebitda (11.02) | Price Sales 812.9166 | Shares Float 107.9 M | Wall Street Target Price 45.6429 |
Arrowhead Pharmaceuticals Stock Price History Chart
There are several ways to analyze Arrowhead Stock price data. The simplest method is using a basic Arrowhead candlestick price chart, which shows Arrowhead Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 23, 2025 | 21.53 |
| Lowest Price | March 21, 2025 | 14.8 |
Arrowhead Pharmaceuticals March 24, 2025 Stock Price Synopsis
Various analyses of Arrowhead Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Arrowhead Stock. It can be used to describe the percentage change in the price of Arrowhead Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Arrowhead Stock.| Arrowhead Pharmaceuticals Price Action Indicator | (0.31) | |
| Arrowhead Pharmaceuticals Price Daily Balance Of Power | (0.58) | |
| Arrowhead Pharmaceuticals Price Rate Of Daily Change | 0.98 |
Arrowhead Pharmaceuticals March 24, 2025 Stock Price Analysis
Arrowhead Stock Price History Data
The price series of Arrowhead Pharmaceuticals for the period between Tue, Dec 24, 2024 and Mon, Mar 24, 2025 has a statistical range of 7.57 with a coefficient of variation of 9.9. The prices are distributed with arithmetic mean of 18.9. The median price for the last 90 days is 19.5. The company had 1:10 stock split on 17th of November 2011. Arrowhead Pharmaceuticals issued dividends on 2010-10-29.| Open | High | Low | Close | Volume | ||
03/24/2025 | 15.11 | 15.22 | 14.69 | 14.80 | ||
| 03/21/2025 | 15.11 | 15.22 | 14.69 | 14.80 | 4,064,707 | |
| 03/20/2025 | 15.27 | 15.72 | 15.07 | 15.11 | 1,788,989 | |
| 03/19/2025 | 15.02 | 15.60 | 14.98 | 15.47 | 1,266,427 | |
| 03/18/2025 | 15.35 | 15.35 | 14.82 | 15.10 | 1,130,474 | |
| 03/17/2025 | 15.34 | 15.86 | 15.01 | 15.60 | 831,542 | |
| 03/14/2025 | 15.21 | 15.62 | 15.13 | 15.36 | 1,103,654 | |
| 03/13/2025 | 15.68 | 15.78 | 14.82 | 15.07 | 1,193,594 | |
| 03/12/2025 | 15.07 | 16.33 | 14.78 | 15.77 | 2,362,202 | |
| 03/11/2025 | 15.33 | 15.56 | 14.23 | 15.06 | 2,026,439 | |
| 03/10/2025 | 16.56 | 16.87 | 15.11 | 15.21 | 2,105,457 | |
| 03/07/2025 | 17.58 | 17.58 | 16.84 | 16.97 | 1,355,433 | |
| 03/06/2025 | 16.91 | 17.79 | 16.83 | 17.67 | 1,165,913 | |
| 03/05/2025 | 17.14 | 17.41 | 16.57 | 17.35 | 1,427,421 | |
| 03/04/2025 | 17.16 | 17.48 | 16.57 | 17.11 | 2,502,324 | |
| 03/03/2025 | 18.94 | 18.97 | 17.61 | 17.71 | 1,640,299 | |
| 02/28/2025 | 18.77 | 19.04 | 18.53 | 18.91 | 1,220,321 | |
| 02/27/2025 | 19.17 | 19.97 | 18.91 | 18.94 | 1,043,161 | |
| 02/26/2025 | 19.72 | 19.98 | 19.08 | 19.23 | 1,130,775 | |
| 02/25/2025 | 19.05 | 19.82 | 18.48 | 19.53 | 1,651,337 | |
| 02/24/2025 | 19.89 | 19.89 | 18.59 | 18.86 | 1,373,395 | |
| 02/21/2025 | 21.20 | 21.31 | 19.88 | 19.90 | 1,201,989 | |
| 02/20/2025 | 21.08 | 21.24 | 20.55 | 20.96 | 1,306,404 | |
| 02/19/2025 | 20.25 | 21.24 | 20.25 | 21.08 | 1,216,444 | |
| 02/18/2025 | 20.00 | 20.76 | 20.00 | 20.44 | 1,071,851 | |
| 02/14/2025 | 19.27 | 20.20 | 19.07 | 19.95 | 930,578 | |
| 02/13/2025 | 18.83 | 19.21 | 18.14 | 19.11 | 1,257,062 | |
| 02/12/2025 | 18.35 | 18.61 | 17.57 | 18.57 | 1,904,865 | |
| 02/11/2025 | 18.23 | 19.80 | 18.23 | 18.89 | 1,772,954 | |
| 02/10/2025 | 20.39 | 20.48 | 19.37 | 19.92 | 1,502,518 | |
| 02/07/2025 | 20.56 | 21.84 | 20.14 | 20.24 | 1,415,520 | |
| 02/06/2025 | 20.32 | 20.53 | 19.95 | 20.48 | 1,264,765 | |
| 02/05/2025 | 19.86 | 20.53 | 19.79 | 20.27 | 1,248,398 | |
| 02/04/2025 | 18.70 | 19.77 | 18.66 | 19.68 | 1,092,568 | |
| 02/03/2025 | 19.03 | 19.44 | 18.55 | 18.74 | 1,620,405 | |
| 01/31/2025 | 20.30 | 20.50 | 19.27 | 19.88 | 1,314,529 | |
| 01/30/2025 | 20.15 | 20.65 | 19.96 | 20.23 | 1,451,298 | |
| 01/29/2025 | 19.88 | 20.30 | 19.69 | 19.95 | 1,295,964 | |
| 01/28/2025 | 20.40 | 20.64 | 19.79 | 20.03 | 1,446,386 | |
| 01/27/2025 | 20.75 | 21.13 | 19.89 | 20.25 | 1,664,923 | |
| 01/24/2025 | 21.23 | 21.73 | 20.37 | 20.76 | 23,746,340 | |
| 01/23/2025 | 20.05 | 21.67 | 19.82 | 21.53 | 3,851,031 | |
| 01/22/2025 | 19.71 | 20.02 | 19.41 | 19.71 | 1,008,237 | |
| 01/21/2025 | 20.00 | 20.48 | 19.57 | 19.76 | 1,338,193 | |
| 01/17/2025 | 19.24 | 19.62 | 18.97 | 19.56 | 931,552 | |
| 01/16/2025 | 18.89 | 19.06 | 18.35 | 19.02 | 1,666,022 | |
| 01/15/2025 | 18.55 | 19.19 | 18.29 | 18.93 | 1,696,615 | |
| 01/14/2025 | 19.04 | 19.07 | 18.02 | 18.05 | 1,236,999 | |
| 01/13/2025 | 18.42 | 18.98 | 17.75 | 18.91 | 2,244,086 | |
| 01/10/2025 | 19.18 | 19.41 | 18.10 | 18.49 | 2,506,156 | |
| 01/08/2025 | 19.32 | 20.78 | 19.32 | 19.75 | 1,715,823 | |
| 01/07/2025 | 19.48 | 20.48 | 19.43 | 19.67 | 1,224,753 | |
| 01/06/2025 | 19.79 | 20.30 | 19.16 | 19.50 | 1,462,454 | |
| 01/03/2025 | 19.67 | 20.54 | 19.56 | 19.79 | 1,039,621 | |
| 01/02/2025 | 18.94 | 19.94 | 18.66 | 19.65 | 1,265,155 | |
| 12/31/2024 | 18.78 | 19.23 | 18.25 | 18.80 | 1,225,959 | |
| 12/30/2024 | 18.86 | 19.03 | 18.40 | 18.61 | 1,126,976 | |
| 12/27/2024 | 19.45 | 20.11 | 18.87 | 18.96 | 1,361,872 | |
| 12/26/2024 | 19.31 | 19.80 | 19.10 | 19.53 | 957,849 | |
| 12/24/2024 | 19.78 | 19.93 | 19.10 | 19.63 | 590,049 | |
| 12/23/2024 | 19.50 | 19.95 | 19.36 | 19.75 | 1,399,271 |
About Arrowhead Pharmaceuticals Stock history
Arrowhead Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arrowhead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arrowhead Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arrowhead Pharmaceuticals stock prices may prove useful in developing a viable investing in Arrowhead Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 137.8 M | 144.6 M | |
| Net Loss | -184.7 M | -175.5 M |
Arrowhead Pharmaceuticals Quarterly Net Working Capital |
|
Arrowhead Pharmaceuticals Stock Technical Analysis
Arrowhead Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Arrowhead Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arrowhead Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Arrowhead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arrowhead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.